A comparison of the fit of flux through hairless mouse skin from water data to three model equations

International Journal of Pharmaceutics

Volumn 366, Issue 1-2, 2009, Pages 65-73

  Wasdo, Scott C ^a   Juntunen, J ^b   Devarajan, H ^a   Sloan, K B ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Diffusion cell experiments; Lipid solubility; Mouse skin; Prodrugs; Roberts Sloan model; Water solubility

Indexed keywords

FLUOROURACIL; MERCAPTOPURINE; MYRISTIC ACID ISOPROPYL ESTER; PARACETAMOL; PRODRUG; THEOPHYLLINE;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG SOLUBILITY; FEMALE; HAIRLESS MOUSE; MODEL; MOUSE; NONHUMAN; PARTITION COEFFICIENT; PRIORITY JOURNAL; SOLUTE;

ANIMALS; DIFFUSION; DRUG DESIGN; FEMALE; HUMANS; MICE; MICE, HAIRLESS; MODELS, BIOLOGICAL; MYRISTATES; PERMEABILITY; PRODRUGS; SKIN; SKIN ABSORPTION; SOLUBILITY; SOLVENTS;

EID: 57849114745     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2008.08.045     Document Type: Article

References (25)

1. Ahmed S., Imai T.L., and Otagiri M. Evaluation of stereoselective transdermal transport and concurrent cutaneous hydrolysis of several ester prodrugs of propranolol: mechanism of stereoselective permeation. Pharm. Res. 13 (1996) 1524-1529
2. Bando H., Mori S., Yamashita F., Takakura Y., and Hashida M. Effects of skin metabolism on percutaneous penetration of lipophilic drug. J. Pharm. Sci. 86 (1997) 759-761
3. Dal Pozzo A., and Pastori N. Percutaneous absorption of parabens from cosmetic formulations. Int. J. Cosmet 18 (1996) 57-66
4. Juntunen J., Majumdar S., and Sloan K.B. The effect of water solubility of solutes on their flux through human skin in vitro: a prodrug database integrated into the extended Flynn database. Int. J. Pharm. 351 (2008) 92-103
5. Kasting G.B., Smith R.L., and Cooper E.R. Effect of lipid solubility and molecular size on percutaneous absorption. In: Shroot B., and Schaefer H. (Eds). Pharmacology and the Skin 1 (1987), Karger, Basel 138-153
6. Magnusson B.M., Anissimov Y.G., Cross S.E., and Roberts M.S. Molecular size as the main determinant of solute maximum flux across the skin. J. Invest. Dermatol. 122 (2004) 993-999
7. Majumdar S., Thomas J.D., Wasdo S.C., and Sloan K.B. The effect of water solubility of solutes on their flux through human skin in vitro. Int. J. Pharm. 329 (2007) 25-36
8. Potts R.O., and Guy R.H. Predicting skin permeability. Pharm. Res. 9 (1992) 663-669
9. Roberts W.J., and Sloan K.B. Correlation of aqueous and lipid solubilities with flux for prodrugs of 5-fluorouracil, theophylline and 6-mercaptopurine: a Potts-Guy approach. J. Pharm. Sci. 88 (1999) 515-532
10. Roberts W.J., and Sloan K.B. Prediction of transdermal flux of prodrugs of 5-fluorouracil, theophylline and 6-mercaptopurine with a series/parallel model. J. Pharm. Sci. 89 (2000) 1415-1431
11. Roberts W.J., and Sloan K.B. Application of the transformed Potts-Guy equation to in vivo human skin data. J. Pharm. Sci. 90 (2001) 1318-1323
12. Roberts W.J., and Sloan K.B. Synthesis of 3-alkylcarbonyloxymethyl derivatives of 5-fluorouracil. J. Heterocyclic Chem. 39 (2002) 905-910
13. Seki T., Kawaguchi T., and Juni K. Enhanced delivery of zidovudine through rat and human skin via ester prodrugs. Pharm. Res. 7 (1990) 948-952
14. Sloan K.B., Koch S.A.M., and Siver K.G. Mannich base derivatives of theophylline and 5-fluorouracil: syntheses, properties and topical delivery characteristics. Int. J. Pharm. 21 (1984) 251-264
15. Sloan K.B., Koch S.A.M., Siver K.G., and Flowers F.P. The use of solubility parameters of drug and vehicle to predict flux. J. Invest. Dermatol. 87 (1986) 244-252
16. Sloan K.B. Prodrugs for dermal delivery. Adv. Drug Deliv. Rev. 3 (1989) 67-101
17. Sloan K.B., Beall H.D., Weimar W.R., and Villaneuva R. The effect of receptor phase composition on the permeability of hairless mouse skin in diffusion cell experiments. Int. J. Pharm. 73 (1991) 97-104
18. Sloan K.B., Taylor H.E., and Hamilton J.C. Alcohol flux and effect on the delivery of theophylline from propylene glycol. Int. J. Pharm. 156 (1997) 17-26
19. Sloan K.B., Wasdo S., Fzike-Mkparu N., Murray T., Nickels D., Singh S., Shanks T., Tovar J., Ulmer K., and Waranis R. Topical delivery of 5-fluorouracil and 6-mercaptopurine by their alkylcarbonyloxymethyl prodrugs from water: vehicle effects on design of prodrugs. Pharm. Res. 20 (2003) 639-645
20. Sloan K.B., Wasdo S.C., and Rautio J. Design for optimized topical delivery: prodrugs and a paradigm change. Pharm. Res. 23 (2006) 2729-2747
21. Stinchcomb A.L., Swaan P.W., Ekabo O., Harris K.K., Browe H., Hammell D.C., Cooperman T.A., and Pearsall M. Straight-chain naltresone ester prodrugs: diffusion and concurrent esterase biotransformation in human skin. J. Pharm. Sci. 91 (2002) 2571-2578
22. Thomas J., Majumdar S., Wasdo S.C., Majumdar A., and Sloan K.B. The effect of water solubility of solutes on their flux through human skin in vitro: an extended Flynn database fitted to the Roberts-Sloan equation. Int. J. Pharm. 339 (2007) 157-167
23. Wasdo S.C., and Sloan K.B. Topical delivery of a model phenolic drug: alkylcarbonyl prodrugs of acetaminophen. Pharm. Res. 21 (2004) 940-946
24. Waranis R.P., and Sloan K.B. The effect of vehicle and prodrug properties and their interactions on the delivery of 6-mercaptopurine through skin: bisacyloxymethyl-6-mercaptopurine prodrugs. J. Pharm. Sci. 76 (1987) 587-595
25. 6-acyloxymethyl-6-mercaptopurine prodrugs. J. Pharm. Sci. 77 (1988) 210-215